SCHEDULE: General Atlantic Boosts Alkami Stake to 11.6%
Beneficial Ownership Disclosure
General Atlantic and its affiliated funds have disclosed a beneficial ownership of 11.6% in Alkami Technology, Inc., holding over 12 million shares for investment purposes.
Summary
- General Atlantic and its affiliated investment funds (the "Reporting Persons") have filed a Schedule 13D, disclosing their beneficial ownership in Alkami Technology, Inc.
- The Reporting Persons collectively beneficially own 12,033,436 shares of Alkami Technology, Inc. common stock.
- This represents 11.6% of the company's total outstanding common stock, based on 104,083,138 shares reported by Alkami as of June 30, 2025.
- The shares were acquired for investment purposes, with funds sourced from the GA Funds and Sponsor Coinvestment Funds.
- The filing supersedes a previously filed Schedule 13G/A from November 4, 2024.
Sentiment
Score: 7
Explanation: The filing indicates a significant investment by a major private equity firm, suggesting confidence in the company's prospects. While it's a disclosure of ownership rather than performance, the intent to engage with management and potentially influence strategy is generally positive for long-term investors.
Positives
- General Atlantic, a prominent investment firm, has taken a significant 11.6% stake, indicating confidence in Alkami Technology, Inc.
- The stated purpose of the investment is for "investment purposes," suggesting a long-term view and potential for strategic engagement.
- The Reporting Persons may engage in communications with company stakeholders and make suggestions regarding operations, strategy, and board composition, potentially leading to improved corporate governance or strategic direction.
Risks
- The Reporting Persons may increase or decrease their investment position, which could lead to volatility in the stock price depending on their actions.
- Future dispositions of a large block of shares by General Atlantic could put downward pressure on Alkami's stock price.
- The Reporting Persons may enter into derivative transactions, which could introduce additional market dynamics and potential volatility.
Future Outlook
The Reporting Persons acquired the common stock for investment purposes and may, from time to time, review their investment position, potentially increasing or decreasing their holdings through open market or privately-negotiated transactions. They may also engage in discussions with company stakeholders regarding operations, strategy, and board composition.
Industry Context
The acquisition of a significant stake by a major private equity firm like General Atlantic in a financial technology company like Alkami Technology, Inc. suggests continued investor interest in the fintech sector. This move could signal a belief in the long-term growth potential of digital banking solutions and financial software providers, aligning with broader trends of digital transformation in the financial services industry.
Stakeholder Impact
- Shareholders: Potential for increased share price stability or volatility depending on General Atlantic's future actions; potential for strategic improvements if General Atlantic engages constructively with management.
- Management/Board: Potential for increased oversight, strategic input, or pressure from a significant institutional investor.
Next Steps
- Reporting Persons may engage in communications with Alkami's shareholders, management, and board of directors.
- Reporting Persons may make suggestions concerning Alkami's operations, prospects, business and financial strategies, strategic transactions, assets and liabilities, business and financing alternatives, and the composition of the board of directors.
- Reporting Persons may increase or decrease their investment position in Alkami common stock.
- Reporting Persons may make additional purchases of common stock in the open market or privately-negotiated transactions.
- Reporting Persons may hold or dispose of all or part of their investments in common stock.
- Reporting Persons may enter into derivative transactions with institutional counterparties with respect to Alkami's securities.
Key Dates
| Date | Description |
|---|---|
| 2024-11-04 | Previous Schedule 13G/A filing date by Reporting Persons. |
| 2025-06-30 | Date as of which Alkami Technology, Inc. reported 104,083,138 shares outstanding in its Form 10-Q. |
| 2025-07-31 | Date Alkami Technology, Inc. filed its Quarterly Report on Form 10-Q with the SEC. |
| 2025-08-06 | Purchase of 100,000 shares at $21.45 and 50,000 shares at $21.42. |
| 2025-08-07 | Purchase of 200,000 shares at $21.12, 200,000 shares at $20.82, and 150,000 shares at $20.91. |
| 2025-08-11 | Purchase of 250,000 shares at $20.72, 250,000 shares at $20.65, and 400,000 shares at $20.73. |
| 2025-08-12 | Purchase of 516,771 shares at $21.46. |
| 2025-08-13 | Date of event requiring filing of this statement; purchase of 100,000 shares at $22.31 and 129,391 shares at $22.54. |
| 2025-08-19 | Date of Joint Filing Agreement. |
| 2025-08-20 | Date of Joint Filing Agreement and signature date of the Schedule 13D filing. |
Keywords
Alkami Technology, General Atlantic, SEC Filing, Schedule 13D, Beneficial Ownership, Investment, Common Stock, Financial Technology, Fintech, Institutional Investor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.